本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ovid Therapeutics Inc.

2.19
-0.2200-9.13%
盘后:2.220.0300+1.37%19:53 EDT
成交量:164.27万
成交额:364.17万
市值:4.27亿
市盈率:-8.64
高:2.42
开:2.41
低:2.18
收:2.41
52周最高:3.11
52周最低:1.18
股本:1.95亿
流通股本:1.63亿
量比:1.23
换手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-0.2535
每股收益(LYR):-0.2325
净资产收益率:-25.96%
总资产收益率:-23.46%
市净率:2.03
市盈率(LYR):-9.42

数据加载中...

2020/05/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/03/30

重要事件披露

Current report, items 8.01 and 9.01
2020/03/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/13

重要事件披露

Current report, items 7.01 and 9.01
2020/03/11

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/03/11

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/11

重要事件披露

Current report, items 2.02 and 9.01
2020/03/02

重要事件披露

Current report, items 7.01 and 9.01
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

重要事件披露

Current report, items 8.01 and 9.01
2019/12/24

重要事件披露

Current report, item 5.02
2019/11/27

超过5%披露

[Amend] General statement of acquisition of beneficial ownership